| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 02/04/1999 | CA2297491A1 Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens |
| 02/03/1999 | EP0894007A1 Porcine reproductive and respiratory syndrome vaccine |
| 02/03/1999 | CN1207124A Recombinant sendal virus |
| 02/03/1999 | CN1207123A (-)-strand RNA virus vector having autonomously replicating activity repliation autonome |
| 02/02/1999 | US5866551 Therapy for atherosclerosis |
| 02/02/1999 | US5866541 Genetic engineering |
| 02/02/1999 | US5866384 Cell ablation using trans-splicing ribozymes |
| 02/02/1999 | US5866326 Hybrids |
| 02/02/1999 | US5866320 Detection antibodies |
| 02/02/1999 | US5866319 Dna probe capacble of hybridizing with genome |
| 02/02/1999 | US5866316 Photodynamic inactivation of enveloped viruses using buckminsterfullerene |
| 02/02/1999 | US5866117 Genetic engineering |
| 02/02/1999 | CA1340378C Non-nuclear chromosomal transformation |
| 01/28/1999 | WO1999004026A2 Lentiviral vectors |
| 01/28/1999 | WO1999004011A2 Hiv-1 group o antigens and uses thereof |
| 01/28/1999 | WO1999003885A1 Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 01/28/1999 | WO1999003328A1 TOXIN GENES FROM THE BACTERIA XENORHABDUS NEMATOPHILUS AND $i(PHOTORHABDUS LUMINESCENS) |
| 01/28/1999 | WO1998049333A3 Eukaryotic gene expression cassette and uses thereof |
| 01/28/1999 | CA2296738A1 Toxin genes from the bacteria xenorhabdus nematophilus and photorhabdus luminescens |
| 01/28/1999 | CA2296442A1 Hiv-1 group o antigens and uses thereof |
| 01/28/1999 | CA2296319A1 Lentiviral vectors |
| 01/27/1999 | EP0892852A2 Cytochrome p450 transducing retroviral vectors |
| 01/26/1999 | US5864016 Treating the blood product with an aqueous solution containing a detergent and heating in the solid state; deactivation of viral activity relative to infectious agents but maintaining at least 50% of its biological activity |
| 01/26/1999 | US5864013 Materials for the production of nanometer structures and use thereof |
| 01/26/1999 | US5863904 Methods for treating cancers and restenosis with P21 |
| 01/26/1999 | US5863797 Gene fusion encoding a hypersecretor protein |
| 01/26/1999 | US5863774 Cell ablation using trans-splicing ribozymes |
| 01/26/1999 | US5863542 Recombinant attenuated ALVAC canaryopox virus containing heterologous HIV or SIV inserts |
| 01/26/1999 | US5863541 Proteins in cells |
| 01/26/1999 | CA2005291C Feline infectious peritonitis virus diagnostic tools |
| 01/21/1999 | WO1999002694A1 Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue |
| 01/21/1999 | WO1999002666A2 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses |
| 01/21/1999 | WO1999002658A1 Inhibiting apoptosis with adenovirus rid protein |
| 01/21/1999 | WO1999002657A1 Rhabdoviruses with reengineered coats |
| 01/21/1999 | WO1999002185A1 Methods and compositions for impairing multiplication of hiv-1 |
| 01/21/1999 | WO1999002184A1 Causative agent of sow abortion and mortality syndrome (sams), vaccine compositions, antibodies and method |
| 01/21/1999 | WO1999002171A1 Vasoprotective recombinant adenovirus vector containing a human tfpi gene |
| 01/21/1999 | CA2332636A1 Vasoprotective recombinant adenovirus vector containing a human tfpi gene |
| 01/21/1999 | CA2295935A1 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses |
| 01/20/1999 | EP0891420A1 Processes for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process |
| 01/20/1999 | CN1041750C Method for suspending, adsorbing and multiplicating virus of hepatitis A |
| 01/19/1999 | US5861282 Mutant constructs; vaccines; genetic engineering |
| 01/19/1999 | US5861163 Immunnology and cells |
| 01/19/1999 | CA1340322C Human papillomavirus type 41, its dna and the proteins encoded therefrom |
| 01/14/1999 | WO1999001557A1 Homogeneous human papilloma virus capsomere containing compositions, methods for manufacture, and the use thereof as diagnostic, prophylactic or therapy |
| 01/14/1999 | WO1999001539A1 A process for purification of pcr test samples |
| 01/13/1999 | EP0890642A2 Retrovirus of the HIV-group and its application |
| 01/13/1999 | EP0889969A1 Recombinant adenoviral vectors for human tumour gene therapy |
| 01/13/1999 | EP0889959A1 Partial intron sequence of von hippel-lindau (vhl) disease gene and its use in diagnosis of disease |
| 01/13/1999 | EP0889955A1 Recombinant phages |
| 01/12/1999 | US5858838 Method for increasing DRAM capacitance via use of a roughened surface bottom capacitor plate |
| 01/12/1999 | US5858775 Adeno-associated virus materials and methods |
| 01/12/1999 | US5858743 Delivery of nucleic acids |
| 01/12/1999 | US5858740 Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells |
| 01/12/1999 | US5858726 Plasmid dna vectors for expression of viral capsid polypeptides and envelope glycoproteins from different virus species; producing self-assembling, non-replicating, non-infectious particles for vaccine and drug therapy |
| 01/12/1999 | US5858651 Nucleotide sequences of human immunodeficiency virus type 2 (HIV-2), probes of HIV-2, and methods of using these probes |
| 01/12/1999 | US5858647 Detecting binding of purified or isolated antigen of hiv-1 subtype o virus to antibodies present in biological sample, comparing to control; diagnosis of infection, aids, and aids related complex; kits |
| 01/12/1999 | US5858643 Red blood cell composition containing vitamin E or derivatives thereof which exhibits reduced potassium ion leakage after a photoinactivation process |
| 01/12/1999 | US5858376 Introducing into cell isolated protein derived from herpes simplex virus |
| 01/12/1999 | US5858374 Purified AIDS-associated virus |
| 01/12/1999 | US5858373 Recombinant poxvirus-feline infectious peritionitis virus, compositions thereof and methods for making and using them |
| 01/12/1999 | US5858353 Insect viruses, sequences, insecticidal compositions and methods |
| 01/12/1999 | US5858351 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors |
| 01/07/1999 | WO1999000510A1 Regulation of transcription in mammalian cells and viral replication by a tetracyclin repressor |
| 01/07/1999 | WO1998039464A3 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
| 01/07/1999 | WO1998039463A3 Lentivirus based vector and vector system |
| 01/07/1999 | EP0888457A1 Adeno-associated virus vector for boosting immunogenicity of cells |
| 01/07/1999 | EP0888046A1 Method of protein production using mitochondrial translation system |
| 01/05/1999 | US5856185 Method for making reflection defective retroviral vectors for infecting human cells |
| 01/05/1999 | US5856181 Cytopathic viruses for therapy and prophylaxis of neoplasia |
| 01/05/1999 | US5856152 Transgenic supplying to cells |
| 01/05/1999 | US5855891 Ichimeric papillomavirus-like particles |
| 01/05/1999 | CA2131415C Vector for liver-specific gene therapy |
| 12/30/1998 | WO1998059063A2 Bovine adenovirus type 3 genome |
| 12/30/1998 | WO1998044944A3 Stabilized human papillomavirus formulations |
| 12/30/1998 | EP0886680A1 Virus-like particle |
| 12/30/1998 | EP0886679A1 Parapoxviruses containing foreign dna, their production and their use in vaccines |
| 12/30/1998 | CN1203626A Method of disrupting cultured cells using impinging jet device |
| 12/30/1998 | CN1203275A Processes for preparation of Marek's disease virus using continuous mammalian cell lines |
| 12/30/1998 | CA2594375A1 Bovine adenovirus type 3 genome |
| 12/29/1998 | US5854037 Recombinant negative strand RNA virus expression systems and vaccines |
| 12/29/1998 | US5853982 Method of isolating strains of the Lymantria dispar nuclear polyhedrosis virus |
| 12/29/1998 | US5853980 Black creek canal hantavirus and related methods |
| 12/29/1998 | US5853735 Avirulent anti-rabies vaccine |
| 12/29/1998 | CA1340288C Generation and selection of novel binding proteins |
| 12/23/1998 | WO1998042830A3 Noey2 gene compositions and methods of use |
| 12/23/1998 | EP0885306A2 Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors |
| 12/23/1998 | EP0885302A1 Recombinant live feline immunodeficiency virus and proviral dna vaccines |
| 12/23/1998 | EP0885018A1 Method and apparatus for inactivating contaminants in biological fluid |
| 12/23/1998 | CN1202932A Therapeutic antiangiogenic compositions and methods |
| 12/23/1998 | CN1202829A Method for preserving microoganisms |
| 12/22/1998 | US5851826 Helper virus-free herpesvirus vector packaging system |
| 12/22/1998 | US5851806 Complementary adenoviral systems and cell lines |
| 12/22/1998 | US5851764 Human prostate tumor inducing gene-1 and uses thereof |
| 12/22/1998 | US5851758 Cytopathic replication of hepatitis C virus in a new cell line |
| 12/22/1998 | US5851545 Insecticidal matrix and process for preparation thereof |
| 12/22/1998 | US5851529 Recombinant retroviruses |
| 12/22/1998 | US5851521 Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis |
| 12/17/1998 | WO1998056937A2 Chimeric vectors comprising a phage packaging site and a portion derived from the genome of a eukaryotic virus |
| 12/17/1998 | WO1998056919A2 Methods and reagents for vaccination which generate a cd8 t cell immune response |